Page 88 - Merck Sharp News Today

New Delhi, Dec. 28 (EFE).- India approved Tuesday the emergency use of the Covovax vaccine, from the US laboratory Novavax, and the indigenous Corbevax, as well as the Molnupiravivir pill, by the American pharmaceutical firm Merck Sharp & Dohme (MSD), in its efforts to fight Covid-19. These new vaccines join the list of five others …

Concurrent tissue- and plasma-based next-generation sequencing (NGS) can be integrated into a for the initial diagnosis of metastatic non-small cell lung cancer (NSCLC), according to a group from the University of Pennsylvania (UPenn) in Philadelphia. Charu Aggarwal, MD, MPH, and colleagues conducted a retrospective study of patients with newly diagnosed stage IV non-squamous NSCLC from December 2018 to December 2019.

India approved Tuesday the emergency use of the Covovax vaccine, from the US laboratory Novavax, and the indigenous Corbevax, as well as the Molnupiravivir pill, by the American pharmaceutical firm Me. India approves use of two new vaccines, anti-covid pill | Main | English edition | Agencia EFE

When the airline industry has a disaster, it goes under review by the National Transportation Safety Board. When corporations dump a toxic brew of chemicals into ground surface waters, they are supposed to answer to the EPA. When drug companies’ products – drugs and vaccines – cause more health problems than they prevent or cure, they are supposed to be subject to recall by the FDA. When regulatory agencies become dominated by the corporations they are supposed to control, that age...

EMERYVILLE, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the appointment of Jessica Hopfield, Ph.D. to the Berkeley

Millions more cutting-edge antiviral treatments for COVID-19 have been secured for NHS patients as the UK Government signs two new contracts to help tackle Omicron.

It is hoped the move will help reduce hospital admissions and therefore ease pressures on the NHS.

The British government has shortened the mandatory Covid-19 self-isolation period in England from 10 days to seven days.

Britain has signed contracts to buy a further 4.25 million courses of antivirals for its health service to help combat the new Omicron variant of coronavirus, it said on Wednesday.... | December 22, 2021

It is hoped the move will help reduce hospital admissions and therefore ease pressures on the NHS.